The continuous glucose monitor system market size has grown rapidly in recent years. It will grow from $9.6 billion in 2025 to $11.05 billion in 2026 at a compound annual growth rate (CAGR) of 15.1%. The growth in the historic period can be attributed to increasing prevalence of diabetes globally, growing awareness of glucose self-monitoring, improved sensor accuracy and reliability, expansion of outpatient diabetes management programs, increased acceptance of wearable medical devices.
The continuous glucose monitor system market size is expected to see rapid growth in the next few years. It will grow to $19.18 billion in 2030 at a compound annual growth rate (CAGR) of 14.8%. The growth in the forecast period can be attributed to increasing adoption of closed-loop insulin delivery systems, rising demand for remote patient monitoring, expansion of personalized diabetes management solutions, growing integration with digital health platforms, increasing focus on non-invasive glucose sensing. Major trends in the forecast period include increasing adoption of smartphone-integrated cgm systems, rising use of real-time glucose monitoring solutions, growing integration of ai-based glucose analytics, expansion of wearable sensor technologies, enhanced focus on continuous patient monitoring.
The growing prevalence of diabetes is expected to drive the expansion of the continuous glucose monitor (CGM) system market. Diabetes is a chronic condition characterized by elevated blood sugar levels, resulting from the body's inability to effectively produce or use insulin. The rise in diabetes is largely due to factors such as increasing obesity rates, poor dietary habits, physical inactivity, and an aging population. CGM systems provide real-time glucose readings, assisting in diabetes management by identifying trends and alerting users to abnormal glucose levels. These systems help improve glycemic control and reduce the need for frequent finger pricks. For example, in June 2024, the National Health Service (NHS), a UK-based government department, reported that in 2023, over half a million (549,000) additional individuals in England were identified as being at risk of developing type 2 diabetes. This brought the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330. This marked a significant increase from 3,065,825 in 2022, reflecting nearly a 20% rise. As a result, the increasing prevalence of diabetes is driving growth in the CGM system market.
Leading companies in the continuous glucose monitor (CGM) system market are working on developing advanced over-the-counter (OTC) CGMs to improve accessibility and reach non-prescription users. An OTC CGM is a device that allows individuals to track their glucose levels in real-time without requiring a prescription, providing a convenient and independent way for consumers to monitor their glucose. For example, in September 2024, Abbott Laboratories, a US-based medical device company, introduced Lingo in the United States. This device is designed for adults without diabetes, enabling users to track their glucose levels and gain valuable insights into how diet and exercise impact their overall health. With a wearability period of up to 14 days, Lingo aligns with Abbott's strategy to cater to the growing market of consumers interested in prediabetes management and wellness, all without the need for a prescription.
In August 2024, Abbott, a US-based manufacturer of continuous glucose monitors, formed a partnership with Medtronic plc to develop an integrated continuous glucose monitoring (CGM) system. The goal of this collaboration is to enhance diabetes management for millions of patients globally who depend on intensive insulin therapy. Medtronic plc, an Ireland-based medical device company, offers CGM systems as part of its product portfolio.
Major companies operating in the continuous glucose monitor system market are Abbott Corporation, Medtronic PLC, Murata Manufacturing Co. Ltd., Dexcom Inc., Sinocare Inc., Tandem Diabetes Care Inc., Ascensia Diabetes Care Holdings AG, Glooko Inc., DarioHealth Corp., Menarini Diagnostics SRL, Senseonics Holdings Inc., WaveForm Technologies Inc., Medtrum Technologies Inc., Biolinq Incorporated, Ultrahuman Inc., GlySens Incorporated, Glucotrack, EOFLOW CO. LTD., Nemaura Medical Inc., Meiqi Medical Equipment, Nipro Diagnostics UK Limited.
North America was the largest region in the continuous glucose monitor (CGM) system market in 2025. The regions covered in the continuous glucose monitor system market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the continuous glucose monitor system market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the continuous glucose monitor system market by increasing costs of imported sensors, transmitters, microelectronics, wireless modules, and medical-grade adhesives. Healthcare providers and patients in North America and Europe are most affected due to reliance on imported CGM components, while Asia-Pacific faces cost pressures on device manufacturing and export activities. These tariffs are raising device prices and impacting affordability. However, they are also encouraging local manufacturing, regional supply chain development, and innovation in cost-optimized and scalable CGM technologies.
The continuous glucose monitor system market research report is one of a series of new reports that provides continuous glucose monitor system market statistics, including continuous glucose monitor system industry global market size, regional shares, competitors with a continuous glucose monitor system market share, detailed continuous glucose monitor system market segments, market trends and opportunities, and any further data you may need to thrive in the continuous glucose monitor system industry. This continuous glucose monitor system market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A continuous glucose monitoring (CGM) system is a medical device designed to provide real-time tracking of glucose levels for individuals with diabetes. The system typically includes a small sensor placed under the skin that measures glucose levels in the interstitial fluid, transmitting the data to a receiver or smartphone app for easy monitoring. This technology helps users make informed decisions about insulin administration and lifestyle choices to effectively manage blood sugar levels.
The main components of a continuous glucose monitoring system include transmitters, receivers, and sensors. Transmitters are devices that convert signals into a form suitable for transmission, allowing data to be sent over distances. The technology includes real-time continuous glucose monitoring and intermittently scanned continuous glucose monitoring, catering to different demographics, including children and adults. CGM systems are used for various applications, such as managing type-1 diabetes, type-2 diabetes, and gestational diabetes, and are utilized by several end users, including diagnostic centers, hospitals, clinics, intensive care units (ICUs), and home healthcare settings.
The continuous glucose monitor system market consists of revenues earned by entities by providing services such as data integration, personalized insights, and remote monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The continuous glucose monitor (CGM) system market also includes sales of sensors, transmitters, data management software, and receivers/display devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The continuous glucose monitor system market size is expected to see rapid growth in the next few years. It will grow to $19.18 billion in 2030 at a compound annual growth rate (CAGR) of 14.8%. The growth in the forecast period can be attributed to increasing adoption of closed-loop insulin delivery systems, rising demand for remote patient monitoring, expansion of personalized diabetes management solutions, growing integration with digital health platforms, increasing focus on non-invasive glucose sensing. Major trends in the forecast period include increasing adoption of smartphone-integrated cgm systems, rising use of real-time glucose monitoring solutions, growing integration of ai-based glucose analytics, expansion of wearable sensor technologies, enhanced focus on continuous patient monitoring.
The growing prevalence of diabetes is expected to drive the expansion of the continuous glucose monitor (CGM) system market. Diabetes is a chronic condition characterized by elevated blood sugar levels, resulting from the body's inability to effectively produce or use insulin. The rise in diabetes is largely due to factors such as increasing obesity rates, poor dietary habits, physical inactivity, and an aging population. CGM systems provide real-time glucose readings, assisting in diabetes management by identifying trends and alerting users to abnormal glucose levels. These systems help improve glycemic control and reduce the need for frequent finger pricks. For example, in June 2024, the National Health Service (NHS), a UK-based government department, reported that in 2023, over half a million (549,000) additional individuals in England were identified as being at risk of developing type 2 diabetes. This brought the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330. This marked a significant increase from 3,065,825 in 2022, reflecting nearly a 20% rise. As a result, the increasing prevalence of diabetes is driving growth in the CGM system market.
Leading companies in the continuous glucose monitor (CGM) system market are working on developing advanced over-the-counter (OTC) CGMs to improve accessibility and reach non-prescription users. An OTC CGM is a device that allows individuals to track their glucose levels in real-time without requiring a prescription, providing a convenient and independent way for consumers to monitor their glucose. For example, in September 2024, Abbott Laboratories, a US-based medical device company, introduced Lingo in the United States. This device is designed for adults without diabetes, enabling users to track their glucose levels and gain valuable insights into how diet and exercise impact their overall health. With a wearability period of up to 14 days, Lingo aligns with Abbott's strategy to cater to the growing market of consumers interested in prediabetes management and wellness, all without the need for a prescription.
In August 2024, Abbott, a US-based manufacturer of continuous glucose monitors, formed a partnership with Medtronic plc to develop an integrated continuous glucose monitoring (CGM) system. The goal of this collaboration is to enhance diabetes management for millions of patients globally who depend on intensive insulin therapy. Medtronic plc, an Ireland-based medical device company, offers CGM systems as part of its product portfolio.
Major companies operating in the continuous glucose monitor system market are Abbott Corporation, Medtronic PLC, Murata Manufacturing Co. Ltd., Dexcom Inc., Sinocare Inc., Tandem Diabetes Care Inc., Ascensia Diabetes Care Holdings AG, Glooko Inc., DarioHealth Corp., Menarini Diagnostics SRL, Senseonics Holdings Inc., WaveForm Technologies Inc., Medtrum Technologies Inc., Biolinq Incorporated, Ultrahuman Inc., GlySens Incorporated, Glucotrack, EOFLOW CO. LTD., Nemaura Medical Inc., Meiqi Medical Equipment, Nipro Diagnostics UK Limited.
North America was the largest region in the continuous glucose monitor (CGM) system market in 2025. The regions covered in the continuous glucose monitor system market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the continuous glucose monitor system market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the continuous glucose monitor system market by increasing costs of imported sensors, transmitters, microelectronics, wireless modules, and medical-grade adhesives. Healthcare providers and patients in North America and Europe are most affected due to reliance on imported CGM components, while Asia-Pacific faces cost pressures on device manufacturing and export activities. These tariffs are raising device prices and impacting affordability. However, they are also encouraging local manufacturing, regional supply chain development, and innovation in cost-optimized and scalable CGM technologies.
The continuous glucose monitor system market research report is one of a series of new reports that provides continuous glucose monitor system market statistics, including continuous glucose monitor system industry global market size, regional shares, competitors with a continuous glucose monitor system market share, detailed continuous glucose monitor system market segments, market trends and opportunities, and any further data you may need to thrive in the continuous glucose monitor system industry. This continuous glucose monitor system market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A continuous glucose monitoring (CGM) system is a medical device designed to provide real-time tracking of glucose levels for individuals with diabetes. The system typically includes a small sensor placed under the skin that measures glucose levels in the interstitial fluid, transmitting the data to a receiver or smartphone app for easy monitoring. This technology helps users make informed decisions about insulin administration and lifestyle choices to effectively manage blood sugar levels.
The main components of a continuous glucose monitoring system include transmitters, receivers, and sensors. Transmitters are devices that convert signals into a form suitable for transmission, allowing data to be sent over distances. The technology includes real-time continuous glucose monitoring and intermittently scanned continuous glucose monitoring, catering to different demographics, including children and adults. CGM systems are used for various applications, such as managing type-1 diabetes, type-2 diabetes, and gestational diabetes, and are utilized by several end users, including diagnostic centers, hospitals, clinics, intensive care units (ICUs), and home healthcare settings.
The continuous glucose monitor system market consists of revenues earned by entities by providing services such as data integration, personalized insights, and remote monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The continuous glucose monitor (CGM) system market also includes sales of sensors, transmitters, data management software, and receivers/display devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Continuous Glucose Monitor System Market Characteristics
3. Continuous Glucose Monitor System Market Supply Chain Analysis
4. Global Continuous Glucose Monitor System Market Trends and Strategies
5. Continuous Glucose Monitor System Market Analysis of End Use Industries
7. Global Continuous Glucose Monitor System Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Continuous Glucose Monitor System Total Addressable Market (TAM) Analysis for the Market
9. Continuous Glucose Monitor System Market Segmentation
10. Continuous Glucose Monitor System Market Regional and Country Analysis
11. Asia-Pacific Continuous Glucose Monitor System Market
12. China Continuous Glucose Monitor System Market
13. India Continuous Glucose Monitor System Market
14. Japan Continuous Glucose Monitor System Market
15. Australia Continuous Glucose Monitor System Market
16. Indonesia Continuous Glucose Monitor System Market
17. South Korea Continuous Glucose Monitor System Market
18. Taiwan Continuous Glucose Monitor System Market
19. South East Asia Continuous Glucose Monitor System Market
20. Western Europe Continuous Glucose Monitor System Market
21. UK Continuous Glucose Monitor System Market
22. Germany Continuous Glucose Monitor System Market
23. France Continuous Glucose Monitor System Market
24. Italy Continuous Glucose Monitor System Market
25. Spain Continuous Glucose Monitor System Market
26. Eastern Europe Continuous Glucose Monitor System Market
27. Russia Continuous Glucose Monitor System Market
28. North America Continuous Glucose Monitor System Market
29. USA Continuous Glucose Monitor System Market
30. Canada Continuous Glucose Monitor System Market
31. South America Continuous Glucose Monitor System Market
32. Brazil Continuous Glucose Monitor System Market
33. Middle East Continuous Glucose Monitor System Market
34. Africa Continuous Glucose Monitor System Market
36. Continuous Glucose Monitor System Market Competitive Landscape and Company Profiles
37. Continuous Glucose Monitor System Market Other Major and Innovative Companies
40. Continuous Glucose Monitor System Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Continuous Glucose Monitor System Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses continuous glucose monitor system market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for continuous glucose monitor system? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The continuous glucose monitor system market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Component: Transmitters; Receivers; Sensor2) By Technology: Real Time Continuous Glucose Monitoring; Intermittently Scanned Continuous Glucose Monitoring
3) By Demography: Child Population; Adult Population
4) By Application: Type-1 Diabetes; Type-2 Diabetes; Gestational Diabetes
5) By End-User: Diagnostics Centers; Hospitals; Clinics; Intensive Care Unit (ICUs); Home Healthcare
Subsegments:
1) By Transmitters: Bluetooth-Enabled Transmitters; Wireless Transmitters2) By Receivers: Dedicated Devices (CGM Receiver); Smartphone-Based Receivers; Cloud-Connected Receivers
3) By Sensor: Enzyme-Based Sensors; Non-Enzyme-Based Sensors; Electrochemical Sensors
Companies Mentioned: Abbott Corporation; Medtronic PLC; Murata Manufacturing Co. Ltd.; Dexcom Inc.; Sinocare Inc.; Tandem Diabetes Care Inc.; Ascensia Diabetes Care Holdings AG; Glooko Inc.; DarioHealth Corp.; Menarini Diagnostics SRL; Senseonics Holdings Inc.; WaveForm Technologies Inc.; Medtrum Technologies Inc.; Biolinq Incorporated; Ultrahuman Inc.; GlySens Incorporated; Glucotrack; EOFLOW CO. LTD.; Nemaura Medical Inc.; Meiqi Medical Equipment; Nipro Diagnostics UK Limited
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Continuous Glucose Monitor System market report include:- Abbott Corporation
- Medtronic PLC
- Murata Manufacturing Co. Ltd.
- Dexcom Inc.
- Sinocare Inc.
- Tandem Diabetes Care Inc.
- Ascensia Diabetes Care Holdings AG
- Glooko Inc.
- DarioHealth Corp.
- Menarini Diagnostics SRL
- Senseonics Holdings Inc.
- WaveForm Technologies Inc.
- Medtrum Technologies Inc.
- Biolinq Incorporated
- Ultrahuman Inc.
- GlySens Incorporated
- Glucotrack
- EOFLOW CO. LTD.
- Nemaura Medical Inc.
- Meiqi Medical Equipment
- Nipro Diagnostics UK Limited
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 11.05 Billion |
| Forecasted Market Value ( USD | $ 19.18 Billion |
| Compound Annual Growth Rate | 14.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
